Develops, manufactures and markets a robust line of rapid diagnostic tests that address some of today's greatest healthcare challenges, including HIV and Hepatitis C.

Free
Message: NR today

The financials are very disappointing. I was expecting better results than that, and am finding it difficult to see anything to be happy about. When the only thing you can highlight as positive is that you are cutting costs, it is not a positive signal to the market.

On the other hand, the SP is low and there is great potential, so I will be hanging in. But today the light at the end of the tunnel is appearing much more dim than it was last week.

Cheers,

Bluenoser

Share
New Message
Please login to post a reply